Literature DB >> 15161565

Three-dimensional conformal brachytherapy for prostate cancer.

Michael J Zelefsky1.   

Abstract

Because innovations in radiation treatment planning have dramatically improved the precision of external beam radiotherapy for prostate cancer with the advent of conformal three-dimensional conformal therapy and intensity modulated radiotherapy, similar developments are emerging for prostate brachytherapy. Computer software programs are facilitating the ability to rapidly create conformal treatment plans in the operating room, taking into account the three-dimensional reconstruction of the prostate target and adhering to dose-volume constraints of the normal tissues including the urethra and rectum. Although excellent dose distributions can be achieved with pre-planning techniques, intraoperative planning takes into account the intraoperative geometry of the prostate and the surrounding normal tissues and can consistently produce seed implants with reduced urethral and rectal doses while delivering the intended prescription dose to the target volume. Current developments are pursuing methods to dynamically modify the treatment plan as the implant procedure is ongoing based on the coordinates of the deposited seeds. Such approaches will minimize the possibility of tumor underdosage and further enhance the conformality of prostate brachytherapy.

Entities:  

Mesh:

Year:  2004        PMID: 15161565     DOI: 10.1007/s11934-004-0034-6

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  24 in total

1.  Intraoperative optimized inverse planning for prostate brachytherapy: early experience.

Authors:  E M Messing; J B Zhang; D J Rubens; R A Brasacchio; J G Strang; A Soni; M C Schell; P G Okunieff; Y Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

2.  Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy.

Authors:  D A Wilkinson; E J Lee; J P Ciezki; D S Mohan; C Zippe; K Angermeier; J Ulchaker; E A Klein; D Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038

Review 3.  The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis.

Authors:  S Nag; W Bice; K DeWyngaert; B Prestidge; R Stock; Y Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-01       Impact factor: 7.038

4.  Prostate gland motion and deformation caused by needle placement during brachytherapy.

Authors:  Nelson N Stone; Jiten Roy; Suzanne Hong; Yeh-Chi Lo; Richard G Stock
Journal:  Brachytherapy       Date:  2002       Impact factor: 2.362

5.  Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.

Authors:  M J Zelefsky; W F Whitmore
Journal:  J Urol       Date:  1997-07       Impact factor: 7.450

6.  A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation.

Authors:  R G Stock; N N Stone; M F Wesson; J K DeWyngaert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-04-30       Impact factor: 7.038

7.  Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

Authors:  M J Zelefsky; K E Wallner; C C Ling; A Raben; T Hollister; T Wolfe; A Grann; P Gaudin; Z Fuks; S A Leibel
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

8.  Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.

Authors:  G S Merrick; W M Butler; R W Galbreath; J H Lief
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

9.  Comparison between two iodine-125 brachytherapy implant techniques: pre-planning and intra-operative by various dosimetry quality indicators.

Authors:  Haim Matzkin; Issac Kaver; Letizia Bramante-Schreiber; Ruben Agai; Ofer Merimsky; Moshe Inbar
Journal:  Radiother Oncol       Date:  2003-09       Impact factor: 6.280

10.  Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.

Authors:  Anthony V D'amico; Clare M Tempany; Delray Schultz; Robert A Cormack; Mark Hurwitz; Clair Beard; Michele Albert; Hanne Kooy; Ferenc Jolesz; Jerome P Richie
Journal:  Urology       Date:  2003-12       Impact factor: 2.649

View more
  3 in total

Review 1.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

Review 2.  Brachytherapy with permanent seed implantation.

Authors:  Shiro Saito; Hirohiko Nagata; Michio Kosugi; Kazuhito Toya; Atsunori Yorozu
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

3.  Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol.

Authors:  Ana Fernandez Ots; Joseph Bucci; Yaw Sinn Chin; David Malouf; Andrew Howie; Komiti Ese Enari
Journal:  JMIR Res Protoc       Date:  2016-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.